Thomas D. Brown - Concepedia

Author

Thomas D. Brown

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Brown, Thomas D.; Taylor, Charles E.; Unione, Alfred J., Ohodnicki, P, R F Ozols, T Brown, T D Brown, T. Brown, THOMAS D. BROWN, Taylor Brown, Thomas Brown, Thomas D Brown

202

Publications

9.7K

Citations

H-Index

145

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Energy Technology Laboratory University of Iowa University of Pittsburgh The University of Texas Health Science Center at San Antonio

About

Thomas D. Brown is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, engineering, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.1K
2	Engineering	13	13	585
3	Health Sciences	8	8	722
4	Public Health	2	2	286
5	Business	1	1	202

Thomas D. Brown

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research Elizabeth Shane, David B. Burr, Peter R. Ebeling, Journal of Bone and Mineral Research	2010	1.1K
Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas Ephraim S. Casper, Mark R. Green, David P. Kelsen, Investigational New Drugs OncologyPhase Ii TrialPancreatic CancerMedicinePancreatic Surgery	1994	440
Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis. Joseph A. Buckwalter, Thomas D. Brown PubMed RheumatologyMusculoskeletal ResearchProgressive DegenerationCartilage DegenerationOsteoarthritis	2004	334
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma Melanie B. Thomas, Romil Chadha, Katrina Y. Glover, Cancer	2007	305
Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer Nora A. Janjan, Christopher H. Crane, Barry W. Feig, American Journal of Clinical Oncology Surgical OncologyRadiation TherapyOverall SurvivalMedicineCancer Recurrence	2001	273
Mercury Measurement and Its Control: What We Know, Have Learned, and Need to Further Investigate Thomas D. Brown, Dennis N. Smith, Richard A. Hargis, Journal of the Air & Waste Management Association PollutionMercury ReleasesMeasurementCalibrationEnvironmental Exposure	1999	202
Phase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano, Journal of Clinical Oncology	2003	195
Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States # Manal M. Hassan, Ahmed O. Kaseb, Donghui Li, Hepatology	2008	169
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research Elizabeth Shane, David B. Burr, Peter R. Ebeling, Journal of Bone and Mineral Research Skeletal TraumaBone DiseaseBone HealthFracture HealingOrthopaedics	2011	144
Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer Sunil Krishnan, Nora A. Janjan, John M. Skibber, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyHealth SciencesRadiation TherapyMedicinePhase Ii Study	2006	115

Page 1